Company Valuation: DNA Investment

Data adjusted to current consolidation scope
Fiscal Period: December 2023 2024 2025
Market Cap 1 43,200 56,400 52,800
Change - 30.56% -6.38%
Enterprise Value (EV) 1 20,569 20,665 44,465
Change - 0.47% 115.17%
P/E 280x -79x 100x
PBR 0.36x 0.47x 0.44x
PEG - 0x -1x
Capitalization / Revenue 0.83x 1.2x 1.59x
EV / Revenue 0.39x 0.44x 1.34x
EV / EBITDA -9.49x 4.64x 23.2x
EV / EBIT -7.74x -579x -27.6x
EV / FCF - - -
FCF Yield - - -
Dividend per Share 2 - - -
Rate of return - - -
EPS 2 12.86 -59.47 43.89
Distribution rate - - -
Net sales 1 52,358 47,137 33,191
EBITDA 1 -2,169 4,458 1,921
EBIT 1 -2,658 -35.71 -1,612
Net income 1 154.4 -713.6 526.7
Net Debt 1 -22,631 -35,735 -8,335
Reference price 2 3,600.00 4,700.00 4,400.00
Nbr of stocks (in thousands) 12,000 12,000 12,000
Announcement Date 21/3/25 21/3/25 31/3/26
1VND in Million2VND
Estimates

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
- - - - 2.37M
17.94x3.22x11.6x4.14% 44.79B
26.87x4.06x17.19x1.25% 23.44B
19.5x2.42x13.09x5.24% 11.55B
15.4x1.75x9.91x3.67% 5.26B
15.64x1.82x10.85x9.4% 3.69B
36.69x4.51x24.57x - 3.05B
18.47x0.87x6.66x1.99% 2.97B
Average 21.50x 2.67x 13.41x 4.28% 11.84B
Weighted average by Cap. 20.73x 3.16x 13.31x 3.65%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. KSD Stock
  4. Valuation DNA Investment